Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference
- 1 June 2004
- journal article
- Published by Wiley in Clinical and Laboratory Haematology
- Vol. 26 (3) , 215-223
- https://doi.org/10.1111/j.1365-2257.2004.00605.x
Abstract
Commercial activated partial thromboplastin time (APTT) reagents prepared with phospholipid extracted from animal or plant sources often differ in their response to heparin and coagulation factors and in their reference values. It is also known that there are variations in phospholipid composition and preparation procedure. The present study attempted to demonstrate that an APTT reagent based on synthetic phospholipids (phosphatidylethanolamine, phosphatidylcholine and phosphatidylserine), which are substances of high purity and homogeneity, reduces batch-to-batch difference when compared with two traditional APTT reagents derived from rabbit brain and soybean. Three types of APTT reagent (SYN-APTT, RBT-APTT, SOY-APTT), prepared respectively from synthetic phospholipid, rabbit brain, and soybean, were tested. The total batch-to-batch difference was coefficient of variation (CV) 0.7-2.4% in the five reagents prepared from synthetic phospholipid (SYN-APTT), but CV 1.5-10.3% in the two traditional reagents (RBT-APTT and SOY-APTT). Additionally, high-performance liquid chromatography (HPLC) analysis showed clear variation in the phospholipid composition of the RBT-APTT and SOY-APTT reagents. In conclusion, the SYN-APTT reagent derived from synthetic phospholipid was shown to reduce batch-to-batch difference, and we therefore suggest that synthetic phospholipid is a substance useful in the preparation of APTT reagent and could contribute to stability of supply and uniform diagnosis.Keywords
This publication has 21 references indexed in Scilit:
- Improved confirmation of weak lupus anticoagulants by employing sensitive and insensitive reagents to the lupus anticoagulantBlood Coagulation & Fibrinolysis, 2001
- A rapid screen for lupus anticoagulant with good discrimination from oral anticoagulants, congenital factor deficiency and heparin, is provided by comparing a sensitive and an insensitive APTT reagentBlood Coagulation & Fibrinolysis, 1997
- Effect of synthetic phospholipids on the response of the activated partial thromboplastin time to heparinBlood Coagulation & Fibrinolysis, 1993
- The preparation of a sensitive partial thromboplastin reagent from bovine brainBlood Coagulation & Fibrinolysis, 1992
- The Variations Between Heparin Sensitivity of Different Lots of Activated Partial Thromboplastin Time Reagent Produced by the Same ManufacturerAmerican Journal of Clinical Pathology, 1988
- Heparin Monitoring by Activated Partial Thromboplastin Time: Comparison of Ex Vivo Measurement and In Vitro Standardization.American Journal of Clinical Pathology, 1985
- The procoagulant activity of partial thromboplastin extracts: The role of phosphatidyl serineThrombosis Research, 1982
- Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating speciesBiochemistry, 1981
- Procoagulant activity of partial thromboplastin (cephalin) reagent and its phospholipid compositionThrombosis Research, 1980
- A Brain Extract as a Substitute for Platelet Suspensions in the Thromboplastin Generation TestNature, 1954